Contact us
US Headquarters:
Dystrogen Therapeutics Corporation
1415 W 37th Street
Chicago, Illinois
EU R&D:
Dystrogen Therapeutics
ul. Kasztelańska 49
Poznań 60-316, PL
NIP: 7792482313
Correspondence address:
USA:
Dystrogen Therapeutics Corporation,
1415 W 37th Street,
Chicago, Illinois
Warsaw Office:
ul. Pytlasińskiego 10/12 lok. 14
00-777 Warszawa, PL
General inquiries: info@dystrogen.com
Investor Relations Contacts: investors@dystrogen.com
Marta Oseka
Vice President of Business Development and Investor Relations
oseka@dystrogen.com